Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 95,070

Document Document Title
WO/2017/033464A1
A method for producing an objective substance such as phytosphingosine and sphinganine using yeast is provided. An objective substance is produced by cultivating yeast having an ability to produce the objective substance and modified so ...  
WO/2017/035270A1
Provided herein are recombinant host cells having an active 3-Hydroxypropionic Acid (3-HP) pathway wherein the host cells comprise a heterologous polynucleotide encoding an aminotransferase of E.C. 2.6.1.19 and wherein the aminotransfera...  
WO/2017/034388A2
Present invention discloses a method of production of Lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/034984A1
The presently disclosed subject matter provides methods for inhibiting the growth and/or survival of bacteria from the Borrelia genus and for treating Lyme disease. These methods include agents that inhibit the glutathione/γ-glutamyl pa...  
WO/2017/033652A1
The present invention addresses the problem of providing a novel short-chain polyhydroxyalkanoate (PHA) having free hydroxy groups and a method for producing the same. Provided are a PHA that comprises, each as a monomer unit, a dihydrox...  
WO/2017/031838A1
Disclosed is a method for producing L-ornithine by whole-cell biotransformation using recombinant Bacillus subtilis, wherein the method comprises constructing Bacillus subtilis 168 engineering bacteria which express arginase originated f...  
WO/2017/031985A1
Provided is an application of Butyribacterintestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.  
WO/2017/034011A1
The present invention pertains to a proliferation agent for increasing, or causing the proliferation of, beneficial intestinal bacteria (primarily, bifidobacteria and/or lactobacilli), the proliferation agent being characterized by conta...  
WO/2017/035191A1
The present invention is a method of enriching at least one bacterial species from a target bacterial system, including: culturing the target bacterial ecosystem in a culture media in a single-stage chemostat under the following conditio...  
WO/2017/033925A1
Provided is a novel butyric acid-producing bacterium that belongs to the Clostridium leptum subgroup, and, in a butyric acid-free culture medium, produces butyric acid but does not produce formic acid.  
WO/2017/034387A2
The embodiments of the present invention relate to a method of producing lignocellulolytic enzymes using a species of white rot fungi by solid stale fermentation (SSF) is provided. The method comprises obtaining artificially modified fun...  
WO/2017/034827A1
A method for increasing the concentration of metal carbonates in a heavy metal contaminated geomaterial utilizing indigenous ureolytic microorganisms. The method may be used for bioremediation of heavy metal contaminated geomaterials.  
WO/2017/032909A1
Disclosed are mutant strains of Staphylococcus aureus with multiple inactivated TCS systems. The invention relates to mutant strains of S. aureus deprived of all non-essential two-component signal systems (TCSs) and even the essential Wa...  
WO/2017/034460A1
The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting...  
WO/2017/031839A1
Provided are an L-asparaginase mutant with improved enzyme activity and a construction method thereof, wherein the mutant is constructed on the basis of the amino acid sequence as shown in the SEQ ID NO.2, in which glycine at position 10...  
WO/2017/035101A1
The present specification discloses plant agent compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a causal agent of a plant disease or increasing plant growth and/or f...  
WO/2017/035188A1
The present invention provides a method, wherein the method treats a subject having a dysbiosis, the method comprising: determining a first metabolic profile of the gut microbiome of a subject having a dysbiosis; changing the first metab...  
WO/2017/034942A1
The present invention relates to the production of chemical species in bacterial host cells. Particularly, the present invention provides for the production of chemical species in Escherichia coli (E. coli) host cells that functionally e...  
WO/2017/034699A1
The present invention is directed to a method and kit for inactivation of acid -fast bacteria. In some embodiments, the method may include: transferring a sample from a liquid culture containing acid-fast bacteria to a first tube, wherei...  
WO/2017/033188A1
Methods of producing algal oil and algal biofuel are provided. Accordingly there is provided a method of producing oil, the method comprising infecting Emiliania huxleyi microalgae with a Coccolithovirus Eh V201; and extracting the oil f...  
WO/2017/032739A1
The present invention relates to methods and pharmaceutical compositions for preventing or treating inflammatory bowel diseases.  
WO/2017/033965A1
Provided is a method for producing an aromatic compound, e.g., salicylic acid, and a derivative thereof with high productivity using a microorganism. Provided are: a method for producing a microorganism having a modified sugar metabolic ...  
WO/2017/029833A1
Provided is a method for site-specific insertion of a foreign DNA into an animal cell genome, said method comprising: (1) a step for constructing a donor plasmid in which 100-300 bp DNAs having a sequence homologous to an insertion site ...  
WO/2017/030503A1
The present invention relates to the field of fermentation biotechnology, more particularly to methods for the fermentative production of massoia lactone by Aureobasidium species.  
WO/2017/031277A1
Provided herein are methods for identifying and obtaining environmental isolates of microorganisms that maintain viability following seed treatment components or seed treatment processes and storage.  
WO/2017/030172A1
A neutral monoclonal antibody useful for effective antibody therapy against Ebola virus is needed. The present invention provides a monoclonal antibody or antigen-binding fragment thereof that is capable of recognizing the GP internal me...  
WO/2017/028040A1
The present invention provides a mycobacterium tuberculosis antigen for differentiating active tuberculosis with latent tuberculosis infection and applications thereof. Specifically, the present invention provides an immunogenic composit...  
WO/2017/030156A1
The present invention pertains to: a monoclonal antibody or a fragment thereof that includes at least one lysine derivative in the constant region of the human IgG antibody; a modified antibody or a fragment thereof in which the lysine d...  
WO/2017/029823A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, a filter is used to separate a biological culture solution including micro-nanobubbles into a filtrate and a concentrate o...  
WO/2017/031211A1
This disclosure concerns compositions and methods for targeting peptides, polypeptides, and proteins to plastids of plastid-containing cells. In some embodiments, the disclosure concerns chloroplast transit peptides that may direct a pol...  
WO/2017/030457A1
The invention relates to the field of protecting plants against pests, and more particularly to a method of protecting plants against pests, which can be used for industrial and scientific purposes, in agriculture, horticulture and fo...  
WO/2017/028151A1
The present invention provides a composite microbial live bacterial agent for effectively degrading aniline in waste water, and a preparation method and application thereof. The composite microbial live bacterial agent comprises Acinetob...  
WO/2017/029733A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, micro-nanobubbles (MNB) are included in a biological culture solution extracted from a culture tank, a filter is used to s...  
WO/2017/025586A1
The present disclosure relates to compositions and methods useful for the production of heterologous proteins in filamentous fungal cells.  
WO/2017/027568A1
The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making bacterial and viral vaccines.  
WO/2017/025648A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid ...  
WO/2017/027821A1
Disclosed are methods for using rhizobial bacteria that are at least partially tolerant to multiple adverse environmental conditions to stimulate growth of plants grown under conditions that are not optimal for plant growth.  
WO/2017/026620A1
The present invention relates to: a Lactobacillus pentosus KF340 strain (deposit number KCCM 11675P); and a composition for preventing, alleviating, or treating Th1-mediated immune diseases, Th17-mediated immune diseases, or Th2-mediated...  
WO/2017/025339A1
The present invention relates to a new process of vanillin production from a substrate by bioconversion and that allows a continuously producing and removing vanillin from the fermentation broth as it is formed. In particular, the invent...  
WO/2017/026173A1
The purpose of the present invention is to provide a method for producing selenoneine with which it is possible to produce selenoneine on an industrial scale because selenoneine can be produced at a higher yield than in the prior art. Th...  
WO/2017/026593A1
The present invention relates to a livestock carcass disposal facility using aerobic thermophilic microorganisms and a burial disposal method. The present invention relates to a livestock carcass disposal facility and a burial disposal m...  
WO/2017/026532A1
The present invention relates to a method for separating cells capable of producing target antigen-specific monoclonal antibodies. In said method: a cell group including antibody-producing cells is immobilized using a crosslinking agent ...  
WO/2017/027490A1
Embodiments include a biological growth device, and related methods for growing biofilms using embodiments of such biological growth device. The device includes a channel configured to convey a fluid medium. A first coupon well is dispos...  
WO/2017/024372A1
The present invention relates to a method for producing a continuous cell line of embryonic-like stem cells, for example from Amblyomma sculptum (Acari: Ixodidae), designated as IBU/ASE-16 (access number in the CNCM: I-5000), and to the ...  
WO/2017/026635A1
The present invention relates to a composition for an animal feed comprising a Lactobacillus sp. strain or dead cells thereof, and a method for producing dead cells of the Lactobacillus sp. strain.  
WO/2017/027723A1
Disclosed herein are methods and compositions for the delivery of polypeptides, including vaccine candidate polypeptides, into mammalian cells comprising the use of photosensitized trypanosomatid organisms. Also disclosed are methods of ...  
WO/2017/026331A1
Provided is an active ingredient of a pharmaceutical composition for myeloma therapy. This antibody has an epitope in a region comprising the 20th to 109th amino acid residues of human integrin β7.  
WO/2017/025649A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35 or SEQ ID NO: 38 ...  
WO/2017/022740A1
A lipid production method for cultivating a transformant having enhanced expression of a gene encoding protein (A) or (B) below, and producing long-chain fatty acids or a lipid having the same as components. (A) Protein comprising an ami...  
WO/2017/024059A1
Disclosed herein are methods of terminally sterilizing bacterial niinicells or compositions comprising bacterial niinicells by exposure to ionizing irradiation. Also disclosed are terminally sterilized bacterial niinicells, pharmaceutica...  

Matches 51 - 100 out of 95,070